Alkermes (ALKS) Receivables - Net (2011 - 2026)
Alkermes (ALKS) recorded Receivables - Net of $456.48 million in Q2 2026, up 28.6% from $354.91 million a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Receivables - Net (2011 - 2026) Analysis & Trends
At the end of FY2025, Alkermes reported Receivables - Net of $334.03 million, down 13.1% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $384.53 million in FY2024 (+15.7%), $332.48 million in FY2023 (+15.5%), $287.97 million in FY2022 (-8.1%) and $313.19 million in FY2021 (+13.8%).
- The Q2 2026 figure is the highest quarterly Receivables - Net in data going back to Q1 2013.
- On a year-over-year basis, Receivables - Net rose in five of the last eight quarters, with growth averaging 7.8%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 36.1% in Q2 2023, against a decline of 17.3% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $407.63 million (Q1 2026), $334.03 million (Q4 2025) and $354.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Alkermes | 6.73 Bn | 3.86 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 456.48 Mn |
| Mar 31, 2026 | 407.63 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Sep 30, 2025 | 354.39 Mn |
| Jun 30, 2025 | 354.91 Mn |
| Mar 31, 2025 | 318.70 Mn |
| Dec 31, 2024 | 384.53 Mn |
| Sep 30, 2024 | 367.21 Mn |
| Jun 30, 2024 | 366.42 Mn |
| Mar 31, 2024 | 315.85 Mn |
| Dec 31, 2023 | 332.48 Mn |
| Sep 30, 2023 | 337.70 Mn |
| Jun 30, 2023 | 334.48 Mn |
| Mar 31, 2023 | 269.18 Mn |
| Dec 31, 2022 | 287.97 Mn |
| Sep 30, 2022 | 257.17 Mn |
| Jun 30, 2022 | 245.84 Mn |
| Mar 31, 2022 | 249.94 Mn |
| Dec 31, 2021 | 313.19 Mn |
| Sep 30, 2021 | 289.16 Mn |
API Access
Alkermes Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();